| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $31.8M | -24.4% |
| SG&A Expense | $22.3M | -3.0% |
| Operating Income | -$54.1M | +16.8% |
| Pre-tax Income | -$44.0M | +31.8% |
| Income Tax | $94K | +159.6% |
| Net Income | -$36.0M | +27.9% |
| EPS (Basic) | -$0.73 | +57.1% |
| EPS (Diluted) | -$0.73 | +57.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $451.2M | +1042.0% |
| Current Assets | $514.2M | +572.0% |
| Total Assets | $526.5M | +585.2% |
| Current Liabilities | $10.0M | +30.0% |
| Total Liabilities | $13.0M | +61.6% |
| Stockholders' Equity | $495.7M | +913.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.8M | +23.5% |
| Capital Expenditures | $285K | +1678.0% |
| Investing Cash Flow | -$25.2M | +22.1% |
| Financing Cash Flow | $479.7M | +300.8% |
| Free Cash Flow | -$43.1M | +23.0% |